Exclusive: Tesla in talks with Chinese firms to buy $2.9 bln worth of solar equipment, sources say
reuters.com
Want to monitor GKOS?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor GKOSglaukos corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world’s leading causes of blindness.